[Form 4] Zymeworks Inc. Insider Trading Activity
EcoR1 Capital, LLC, together with its affiliated fund and managing member Oleg Nodelman, filed a Form 4 disclosing the cashless exercise of 5,086,521 pre-funded warrants in Zymeworks Inc. (ticker: ZYME) on 26 Jun 2025.
- The warrants carried a nominal exercise price of $0.0001 per share. To settle the aggregate exercise price, the reporting persons instructed the issuer to withhold 41 shares (valued at $12.71 each), issuing the remaining 5,086,480 new common shares.
- Following the transaction, EcoR1鈥檚 Qualified Fund owns 21,582,563 ZYME shares and the group reports total indirect beneficial ownership of 22,970,388 shares.
- The derivative position (pre-funded warrants) is now fully exhausted; the reporting persons hold 0 derivative securities post-transaction.
- EcoR1 and Mr. Nodelman are both classified as 10% owners and hold board seats, reinforcing their strategic involvement with the company.
The filing signals continued insider alignment through an increase in equity exposure; however, it also converts previously outstanding warrants into issued equity, modestly expanding the public float.
EcoR1 Capital, LLC, insieme al suo fondo affiliato e al membro gestore Oleg Nodelman, ha depositato un Modulo 4 rivelando l'esercizio senza pagamento in contanti di 5.086.521 warrant pre-finanziati in Zymeworks Inc. (ticker: ZYME) il 26 giugno 2025.
- I warrant avevano un prezzo nominale di esercizio di $0,0001 per azione. Per regolare il prezzo complessivo di esercizio, le persone che hanno effettuato la comunicazione hanno istruito l'emittente a trattenere 41 azioni (valutate $12,71 ciascuna), emettendo le restanti 5.086.480 nuove azioni ordinarie.
- A seguito della transazione, il Fondo Qualificato di EcoR1 possiede 21.582.563 azioni ZYME e il gruppo dichiara una propriet脿 indiretta totale di 22.970.388 azioni.
- La posizione derivata (warrant pre-finanziati) 猫 ora completamente esaurita; le persone che hanno effettuato la comunicazione detengono 0 titoli derivati dopo la transazione.
- EcoR1 e il Sig. Nodelman sono entrambi classificati come proprietari del 10% e occupano seggi nel consiglio di amministrazione, rafforzando il loro coinvolgimento strategico con la societ脿.
La comunicazione segnala un continuo allineamento degli insider attraverso un aumento dell'esposizione azionaria; tuttavia, converte anche warrant precedentemente in circolazione in azioni emesse, ampliando modestamente il flottante pubblico.
EcoR1 Capital, LLC, junto con su fondo afiliado y el miembro gerente Oleg Nodelman, present贸 un Formulario 4 revelando el ejercicio sin efectivo de 5,086,521 warrants prefinanciados en Zymeworks Inc. (ticker: ZYME) el 26 de junio de 2025.
- Los warrants ten铆an un precio nominal de ejercicio de $0.0001 por acci贸n. Para saldar el precio total de ejercicio, las personas que informaron instruyeron al emisor retener 41 acciones (valoradas en $12.71 cada una), emitiendo las restantes 5,086,480 nuevas acciones ordinarias.
- Tras la transacci贸n, el Fondo Calificado de EcoR1 posee 21,582,563 acciones de ZYME y el grupo reporta una propiedad indirecta total de 22,970,388 acciones.
- La posici贸n derivada (warrants prefinanciados) est谩 ahora completamente agotada; las personas que informaron no poseen 苍颈苍驳煤苍 valor derivado tras la transacci贸n.
- EcoR1 y el Sr. Nodelman est谩n clasificados como propietarios del 10% y ocupan puestos en la junta directiva, reforzando su participaci贸n estrat茅gica en la compa帽铆a.
La presentaci贸n indica una continua alineaci贸n interna mediante un aumento en la exposici贸n accionaria; sin embargo, tambi茅n convierte warrants previamente pendientes en acciones emitidas, ampliando modestamente el flotante p煤blico.
EcoR1 Capital, LLC電� 瓿勳棿 韼�霌� 氚� 甏�毽� 氅る矂 Oleg Nodelman瓿� 頃粯 2025雲� 6鞗� 26鞚� Zymeworks Inc.(韹办护: ZYME)鞐愳劀 5,086,521臧滌潣 靹犾旮� 鞗岆煱韸胳潣 順勱笀 鞐嗠姅 頄夓偓 雮挫毄鞚� 雼挫潃 Form 4毳� 鞝滌稖頄堨姷雼堧嫟.
- 鞗岆煱韸胳潣 氇呺 頄夓偓 臧�瓴╈潃 欤茧嫻 $0.0001鞚挫棃鞀惦媹雼�. 齑� 頄夓偓 雽�旮堨潉 鞝曥偘頃橁赴 鞙勴暣 氤搓碃鞛愲姅 氚滍枆靷棎 41欤�(欤茧嫻 $12.71 臧�旃�)毳� 鞗愳矞歆曥垬頃橂弰搿� 歆�鞁滍晿瓿�, 雮橂ǜ歆� 5,086,480欤检潣 鞁犾＜ 氤错喌欤�毳� 氚滍枆頄堨姷雼堧嫟.
- 瓯半灅 頉� EcoR1鞚� 鞝侁博 韼�霌滊姅 21,582,563欤�鞚� ZYME 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨溂氅�, 攴鸽９鞚� 齑� 臧勳爲 靻岇湢 歆�攵� 22,970,388欤�毳� 氤搓碃頃╇媹雼�.
- 韺岇儩靸來拡 韽靺�(靹犾旮� 鞗岆煱韸�)鞚� 鞚挫牅 鞕勳爠頌� 靻岇霅橃棃鞙茧┌, 氤搓碃鞛愲姅 瓯半灅 頉� 0臧滌潣 韺岇儩靸來拡鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
- EcoR1瓿� Nodelman 鞌姅 氇憪 10% 靻岇湢欤�搿� 攵勲霅橂┌ 鞚挫偓須岇棎霃� 彀胳棳頃橃棳 須岇偓鞕�鞚� 鞝勲灥鞝� 鞐瓣硠毳� 臧曧檾頃橁碃 鞛堨姷雼堧嫟.
鞚措矆 鞝滌稖鞚� 歆�攵� 雲胳稖 歃濌皜毳� 韱淀暅 雮措秬鞛� 臧� 歆�靻嶌爜鞚� 鞝曤牞鞚� 雮橅儉雮挫毵�, 霃欖嫓鞐� 旮办〈鞐� 氙戈舶鞝滊悳 鞗岆煱韸鸽ゼ 氚滍枆 欤检嫕鞙茧 鞝勴櫂頃橃棳 瓿惦 鞙犿喌 欤检嫕 靾橂ゼ 雼れ唽 頇曤寑頃╇媹雼�.
EcoR1 Capital, LLC, avec son fonds affili茅 et le membre gestionnaire Oleg Nodelman, a d茅pos茅 un formulaire 4 r茅v茅lant l'exercice sans num茅raire de 5 086 521 bons de souscription pr茅financ茅s dans Zymeworks Inc. (symbole : ZYME) le 26 juin 2025.
- Les bons avaient un prix d'exercice nominal de 0,0001 $ par action. Pour r茅gler le prix d'exercice global, les d茅clarants ont demand茅 脿 l'茅metteur de retenir 41 actions (valoris茅es 脿 12,71 $ chacune), 茅mettant les 5 086 480 nouvelles actions ordinaires restantes.
- 脌 la suite de la transaction, le fonds qualifi茅 d'EcoR1 d茅tient 21 582 563 actions ZYME et le groupe d茅clare une propri茅t茅 indirecte totale de 22 970 388 actions.
- La position d茅riv茅e (bons pr茅financ茅s) est d茅sormais enti猫rement 茅puis茅e ; les d茅clarants ne d茅tiennent plus aucun titre d茅riv茅 apr猫s la transaction.
- EcoR1 et M. Nodelman sont tous deux class茅s comme d茅tenteurs de 10 % et si猫gent au conseil d'administration, renfor莽ant leur implication strat茅gique dans la soci茅t茅.
Le d茅p么t signale une continuit茅 dans l'alignement des initi茅s gr芒ce 脿 une augmentation de l'exposition en actions ; cependant, il convertit 茅galement des bons pr茅c茅demment en circulation en actions 茅mises, 茅largissant modestement le flottant public.
EcoR1 Capital, LLC hat zusammen mit seinem verbundenen Fonds und dem gesch盲ftsf眉hrenden Mitglied Oleg Nodelman am 26. Juni 2025 ein Formular 4 eingereicht, das die bargeldlose Aus眉bung von 5.086.521 vorfinanzierten Warrants bei Zymeworks Inc. (Ticker: ZYME) offenlegt.
- Die Warrants hatten einen nominalen Aus眉bungspreis von $0,0001 pro Aktie. Zur Begleichung des Gesamt-Aus眉bungspreises wiesen die meldenden Personen den Emittenten an, 41 Aktien (jeweils im Wert von $12,71) einzubehalten und die verbleibenden 5.086.480 neuen Stammaktien auszugeben.
- Nach der Transaktion besitzt der qualifizierte Fonds von EcoR1 21.582.563 ZYME-Aktien, und die Gruppe meldet einen gesamten indirekten wirtschaftlichen Eigentum von 22.970.388 Aktien.
- Die Derivatposition (vorfinanzierte Warrants) ist nun vollst盲ndig ersch枚pft; die meldenden Personen halten nach der Transaktion 0 derivative Wertpapiere.
- EcoR1 und Herr Nodelman sind beide als 10%-贰颈驳别苍迟眉尘别谤 klassifiziert und besitzen Sitze im Vorstand, was ihr strategisches Engagement im Unternehmen unterstreicht.
Die Meldung signalisiert eine fortgesetzte Insider-Ausrichtung durch eine Erh枚hung der Aktienexponierung; gleichzeitig werden zuvor ausstehende Warrants in ausgegebene Aktien umgewandelt, wodurch der Streubesitz moderat erweitert wird.
- Insider confidence: 10% owner EcoR1 converted 5.1 M warrants, increasing its direct equity exposure.
- Removal of derivative overhang: All pre-funded warrants are now exercised, simplifying capital structure.
- Enhanced alignment: Board-affiliated investor now holds 22.97 M common shares, strengthening governance accountability.
- Share count increase: Issuance of 5.09 M new shares marginally dilutes existing shareholders.
- No cash inflow: Nominal $0.0001 exercise price yields de-minimis capital to the company.
Insights
TL;DR: EcoR1 converted 5.1 M pre-funded warrants, boosting its common share stake to 23 M and eliminating warrant overhang.
The warrant exercise adds 5.1 M shares to the outstanding count at a de-minimis cost, indicating EcoR1鈥檚 ongoing commitment as a long-term holder. Because pre-funded warrants are typically included in diluted share calculations, the impact on fully-diluted EPS is likely limited. Nonetheless, the shift from derivative to common stock removes execution risk and signals insider confidence, which investors often interpret positively. The small share withholding (41 shares) to cover exercise costs is immaterial. Overall, this is a constructive insider transaction with negligible cash inflow to the company.
TL;DR: Director/10% owner deepens equity stake, reinforcing governance influence.
EcoR1 and Oleg Nodelman already hold board representation; converting the warrants increases their voting power by roughly 5 million shares, further entrenching their influence. Because the exercise price is negligible, there is no meaningful capital contribution to the issuer, but the move aligns board and shareholder interests by turning options into vested ownership. No new compensation or dilution beyond what was already disclosed under the warrant terms arises. Overall governance impact is positive due to stronger insider alignment, with limited negative effects apart from a minor uptick in issued share count.
EcoR1 Capital, LLC, insieme al suo fondo affiliato e al membro gestore Oleg Nodelman, ha depositato un Modulo 4 rivelando l'esercizio senza pagamento in contanti di 5.086.521 warrant pre-finanziati in Zymeworks Inc. (ticker: ZYME) il 26 giugno 2025.
- I warrant avevano un prezzo nominale di esercizio di $0,0001 per azione. Per regolare il prezzo complessivo di esercizio, le persone che hanno effettuato la comunicazione hanno istruito l'emittente a trattenere 41 azioni (valutate $12,71 ciascuna), emettendo le restanti 5.086.480 nuove azioni ordinarie.
- A seguito della transazione, il Fondo Qualificato di EcoR1 possiede 21.582.563 azioni ZYME e il gruppo dichiara una propriet脿 indiretta totale di 22.970.388 azioni.
- La posizione derivata (warrant pre-finanziati) 猫 ora completamente esaurita; le persone che hanno effettuato la comunicazione detengono 0 titoli derivati dopo la transazione.
- EcoR1 e il Sig. Nodelman sono entrambi classificati come proprietari del 10% e occupano seggi nel consiglio di amministrazione, rafforzando il loro coinvolgimento strategico con la societ脿.
La comunicazione segnala un continuo allineamento degli insider attraverso un aumento dell'esposizione azionaria; tuttavia, converte anche warrant precedentemente in circolazione in azioni emesse, ampliando modestamente il flottante pubblico.
EcoR1 Capital, LLC, junto con su fondo afiliado y el miembro gerente Oleg Nodelman, present贸 un Formulario 4 revelando el ejercicio sin efectivo de 5,086,521 warrants prefinanciados en Zymeworks Inc. (ticker: ZYME) el 26 de junio de 2025.
- Los warrants ten铆an un precio nominal de ejercicio de $0.0001 por acci贸n. Para saldar el precio total de ejercicio, las personas que informaron instruyeron al emisor retener 41 acciones (valoradas en $12.71 cada una), emitiendo las restantes 5,086,480 nuevas acciones ordinarias.
- Tras la transacci贸n, el Fondo Calificado de EcoR1 posee 21,582,563 acciones de ZYME y el grupo reporta una propiedad indirecta total de 22,970,388 acciones.
- La posici贸n derivada (warrants prefinanciados) est谩 ahora completamente agotada; las personas que informaron no poseen 苍颈苍驳煤苍 valor derivado tras la transacci贸n.
- EcoR1 y el Sr. Nodelman est谩n clasificados como propietarios del 10% y ocupan puestos en la junta directiva, reforzando su participaci贸n estrat茅gica en la compa帽铆a.
La presentaci贸n indica una continua alineaci贸n interna mediante un aumento en la exposici贸n accionaria; sin embargo, tambi茅n convierte warrants previamente pendientes en acciones emitidas, ampliando modestamente el flotante p煤blico.
EcoR1 Capital, LLC電� 瓿勳棿 韼�霌� 氚� 甏�毽� 氅る矂 Oleg Nodelman瓿� 頃粯 2025雲� 6鞗� 26鞚� Zymeworks Inc.(韹办护: ZYME)鞐愳劀 5,086,521臧滌潣 靹犾旮� 鞗岆煱韸胳潣 順勱笀 鞐嗠姅 頄夓偓 雮挫毄鞚� 雼挫潃 Form 4毳� 鞝滌稖頄堨姷雼堧嫟.
- 鞗岆煱韸胳潣 氇呺 頄夓偓 臧�瓴╈潃 欤茧嫻 $0.0001鞚挫棃鞀惦媹雼�. 齑� 頄夓偓 雽�旮堨潉 鞝曥偘頃橁赴 鞙勴暣 氤搓碃鞛愲姅 氚滍枆靷棎 41欤�(欤茧嫻 $12.71 臧�旃�)毳� 鞗愳矞歆曥垬頃橂弰搿� 歆�鞁滍晿瓿�, 雮橂ǜ歆� 5,086,480欤检潣 鞁犾＜ 氤错喌欤�毳� 氚滍枆頄堨姷雼堧嫟.
- 瓯半灅 頉� EcoR1鞚� 鞝侁博 韼�霌滊姅 21,582,563欤�鞚� ZYME 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨溂氅�, 攴鸽９鞚� 齑� 臧勳爲 靻岇湢 歆�攵� 22,970,388欤�毳� 氤搓碃頃╇媹雼�.
- 韺岇儩靸來拡 韽靺�(靹犾旮� 鞗岆煱韸�)鞚� 鞚挫牅 鞕勳爠頌� 靻岇霅橃棃鞙茧┌, 氤搓碃鞛愲姅 瓯半灅 頉� 0臧滌潣 韺岇儩靸來拡鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
- EcoR1瓿� Nodelman 鞌姅 氇憪 10% 靻岇湢欤�搿� 攵勲霅橂┌ 鞚挫偓須岇棎霃� 彀胳棳頃橃棳 須岇偓鞕�鞚� 鞝勲灥鞝� 鞐瓣硠毳� 臧曧檾頃橁碃 鞛堨姷雼堧嫟.
鞚措矆 鞝滌稖鞚� 歆�攵� 雲胳稖 歃濌皜毳� 韱淀暅 雮措秬鞛� 臧� 歆�靻嶌爜鞚� 鞝曤牞鞚� 雮橅儉雮挫毵�, 霃欖嫓鞐� 旮办〈鞐� 氙戈舶鞝滊悳 鞗岆煱韸鸽ゼ 氚滍枆 欤检嫕鞙茧 鞝勴櫂頃橃棳 瓿惦 鞙犿喌 欤检嫕 靾橂ゼ 雼れ唽 頇曤寑頃╇媹雼�.
EcoR1 Capital, LLC, avec son fonds affili茅 et le membre gestionnaire Oleg Nodelman, a d茅pos茅 un formulaire 4 r茅v茅lant l'exercice sans num茅raire de 5 086 521 bons de souscription pr茅financ茅s dans Zymeworks Inc. (symbole : ZYME) le 26 juin 2025.
- Les bons avaient un prix d'exercice nominal de 0,0001 $ par action. Pour r茅gler le prix d'exercice global, les d茅clarants ont demand茅 脿 l'茅metteur de retenir 41 actions (valoris茅es 脿 12,71 $ chacune), 茅mettant les 5 086 480 nouvelles actions ordinaires restantes.
- 脌 la suite de la transaction, le fonds qualifi茅 d'EcoR1 d茅tient 21 582 563 actions ZYME et le groupe d茅clare une propri茅t茅 indirecte totale de 22 970 388 actions.
- La position d茅riv茅e (bons pr茅financ茅s) est d茅sormais enti猫rement 茅puis茅e ; les d茅clarants ne d茅tiennent plus aucun titre d茅riv茅 apr猫s la transaction.
- EcoR1 et M. Nodelman sont tous deux class茅s comme d茅tenteurs de 10 % et si猫gent au conseil d'administration, renfor莽ant leur implication strat茅gique dans la soci茅t茅.
Le d茅p么t signale une continuit茅 dans l'alignement des initi茅s gr芒ce 脿 une augmentation de l'exposition en actions ; cependant, il convertit 茅galement des bons pr茅c茅demment en circulation en actions 茅mises, 茅largissant modestement le flottant public.
EcoR1 Capital, LLC hat zusammen mit seinem verbundenen Fonds und dem gesch盲ftsf眉hrenden Mitglied Oleg Nodelman am 26. Juni 2025 ein Formular 4 eingereicht, das die bargeldlose Aus眉bung von 5.086.521 vorfinanzierten Warrants bei Zymeworks Inc. (Ticker: ZYME) offenlegt.
- Die Warrants hatten einen nominalen Aus眉bungspreis von $0,0001 pro Aktie. Zur Begleichung des Gesamt-Aus眉bungspreises wiesen die meldenden Personen den Emittenten an, 41 Aktien (jeweils im Wert von $12,71) einzubehalten und die verbleibenden 5.086.480 neuen Stammaktien auszugeben.
- Nach der Transaktion besitzt der qualifizierte Fonds von EcoR1 21.582.563 ZYME-Aktien, und die Gruppe meldet einen gesamten indirekten wirtschaftlichen Eigentum von 22.970.388 Aktien.
- Die Derivatposition (vorfinanzierte Warrants) ist nun vollst盲ndig ersch枚pft; die meldenden Personen halten nach der Transaktion 0 derivative Wertpapiere.
- EcoR1 und Herr Nodelman sind beide als 10%-贰颈驳别苍迟眉尘别谤 klassifiziert und besitzen Sitze im Vorstand, was ihr strategisches Engagement im Unternehmen unterstreicht.
Die Meldung signalisiert eine fortgesetzte Insider-Ausrichtung durch eine Erh枚hung der Aktienexponierung; gleichzeitig werden zuvor ausstehende Warrants in ausgegebene Aktien umgewandelt, wodurch der Streubesitz moderat erweitert wird.
FAQ
How many ZYME shares did EcoR1 acquire on 26 Jun 2025?
What is EcoR1鈥檚 total ownership in Zymeworks after the Form 4 transaction?
Were any derivative securities still outstanding after the warrant exercise?
Did Zymeworks receive significant cash from the warrant exercise?
Does EcoR1 hold board representation at Zymeworks?
